Browsing: Obesity
Oral Semaglutide (Wegovy)Oral semaglutide (Wegovy) was approved by the U.S. Food and Drug Administration (FDA) in December 2025 as a treatment…
For decades, the world has watched Oprah Winfrey’s very public battle with her weight, as she yo-yoed between sizes, inspiring…
Breast cancer survivors with an inherited risk for obesity have a higher risk of dying early compared with survivors without…
Rapid weight loss with GLP‑1 medications affects more than just body fat; it also reduces fat-free mass, including muscle, bone,…
The U.S. Food and Drug Administration (FDA) has approved the first GLP-1 pill to reduce excess body weight, introducing a…
An experimental obesity drug called retatrutide that targets GLP-1 and two other hormones helped people lose nearly one-third of their…
In a landmark decision that will reshape how we approach obesity treatment worldwide, the World Health Organization1 has released its…
Choosing between Wegovy and Zepbound comes down to finding the option that fits your health goals, lifestyle, and what feels…
Obesity has boomed in industrialized nations over the last century, and a common explanation is that we’ve become more sedentary,…
Insulin resistance is most well known as a cause of type 2 diabetes, but experts today recognize that it creates…